Showing results (2151-2160 of 2,234) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|April 6, 2017
Discrepancy Between Tumor Antigen Distribution and Radiolabeled Antibody Binding in a Nude Mouse Xenograft Model of Human MelanomaYong-Il Kim, Jin Chul Paeng, Gi Jeong Cheon, et al.Cancer Biotherapy & Radiopharmaceuticals|April 18, 2017
Expression of Long Noncoding RNA Urothelial Cancer Associated 1 Promotes Cisplatin Resistance in Cervical CancerBi Wang, Zhi Huang, Rui Gao, et al.Cancer Biotherapy & Radiopharmaceuticals|July 23, 2019
Correction to: Cancer Biother Radiopharm 2014;29(8):303-309. DOI: 10.1089/cbr.2014.1653 and Cancer Biother Radiopharm 2014;29(10):451-456. DOI: 10.1089/cbr.2014.1698Cancer Biotherapy & Radiopharmaceuticals|July 12, 2019
Clinical and Imaging Characteristics of Malignant Tumor Concurrent with StrokeFeng Wang, Xiao-Yun Hu, Zhi-Ming Cui, et al.Cancer Biotherapy & Radiopharmaceuticals|January 25, 2017
Cytotoxic Effects of the Therapeutic Radionuclide Rhenium-188 Combined with Taxanes in Human Prostate Carcinoma Cell LinesRogier Lange, Rob ter Heine, Wessel N van Wieringen, et al.Cancer Biotherapy & Radiopharmaceuticals|January 25, 2017
Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses Cervical Cancer Invasion Through Inhibition of Urokinase-Type Plasminogen ActivatorTipattaraporn Panich, Khajornsak Tragoolpua, Supansa Pata, et al.Cancer Biotherapy & Radiopharmaceuticals|January 25, 2017
PARP-1 Expression Quantified by [18F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation TherapySamuel Sander Effron, Mehran Makvandi, Lilie Lin, et al.Cancer Biotherapy & Radiopharmaceuticals|February 21, 2014
Expression of different neurokinin-1 receptor (NK1R) isoforms in glioblastoma multiforme: potential implications for targeted therapyDominik Cordier, Alexandra Gerber, Christiane Kluba, et al.Cancer Biotherapy & Radiopharmaceuticals|December 27, 2007
Molecular imaging and personalized medicine: an uncertain futureAdrian D NunnCancer Biotherapy & Radiopharmaceuticals|December 27, 2007
Role of FDG-PET in the assessment of survival prognosis in melanomaChristiane Pleiss, Jörn H Risse, Hans-Jürgen Biersack, et al.Pageof 224